Candida Krusei BY PCR

The Candida Krusei BY PCR is a molecular test that detects Candida krusei DNA from home-collected vaginal swabs or urine samples, providing species-level identification with greater sensitivity and speed than conventional culture. Identification is clinically important because C. krusei commonly shows intrinsic resistance to fluconazole, so PCR results help guide targeted antifungal therapy and inform management of recurrent vaginal or urinary yeast infections. Touch Connect’s confidential lab‑at‑home service offers discreet sample pickup and rapid reporting across Dubai and the UAE; results should be reviewed with a licensed clinician to determine appropriate treatment in line with local practice.

• Candida krusei DNA (PCR)
• Qualitative result — Detected / Not detected
• Cycle threshold (Ct) value
• Internal amplification control (IAC)
• Accepted specimen types: Vaginal swab, Urine, Urethral swab, Blood (EDTA)

• Sensitive PCR assay specifically detecting Candida krusei DNA for accurate species identification
• Distinguishes C. krusei from other Candida species to inform targeted antifungal therapy
• Detects low fungal loads from genital, urinary or blood-derived home samples for early diagnosis
• Confidential at-home sample collection across Dubai and the UAE by trained collectors
• Fast electronic results (typically 24–48 hours) with clinical notes on intrinsic azole resistance

• Highly sensitive PCR assay for specific detection of Candida krusei, minimizing cross-reactivity with other Candida species
• Detects Candida krusei from vaginal swab, urine or blood specimens, suitable for vulvovaginal, urinary and invasive infection screening
• Confidential home sample collection by trained technicians across Dubai and the UAE, following DHA-aligned privacy and safety protocols
• Rapid laboratory turnaround with secure online results and downloadable report — typical delivery within 24–48 hours
• Includes clear result interpretation and option for follow-up consultation or referral to specialist clinicians in the UAE

• PCR-based species-specific detection of Candida krusei from vaginal, urine or genital swabs with high sensitivity
• Detects intrinsically azole-resistant C. krusei to inform targeted antifungal treatment and avoid ineffective fluconazole therapy
• Confidential home sample collection across Dubai and the UAE with discreet packaging and trained collectors
• Secure online results delivered typically within 24–48 hours from lab receipt; testing conducted in UAE‑accredited laboratories